nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Carbamazepine—epilepsy syndrome	0.266	1	CrCtD
Cyproheptadine—schizophrenia—Lamotrigine—epilepsy syndrome	0.0652	0.332	CpDpCtD
Cyproheptadine—CHRM3—epilepsy syndrome	0.0534	0.325	CbGaD
Cyproheptadine—CHRM1—epilepsy syndrome	0.0498	0.303	CbGaD
Cyproheptadine—schizophrenia—Carbamazepine—epilepsy syndrome	0.0494	0.252	CpDpCtD
Cyproheptadine—UGT1A3—Lamotrigine—epilepsy syndrome	0.0478	0.66	CbGbCtD
Cyproheptadine—schizophrenia—Valproic Acid—epilepsy syndrome	0.042	0.214	CpDpCtD
Cyproheptadine—CHRM2—epilepsy syndrome	0.0407	0.248	CbGaD
Cyproheptadine—schizophrenia—Clonazepam—epilepsy syndrome	0.0395	0.201	CpDpCtD
Cyproheptadine—UGT1A3—Valproic Acid—epilepsy syndrome	0.0246	0.34	CbGbCtD
Cyproheptadine—HTR2A—epilepsy syndrome	0.0203	0.124	CbGaD
Cyproheptadine—Protriptyline—Carbamazepine—epilepsy syndrome	0.0155	0.0825	CrCrCtD
Cyproheptadine—Phenindione—Fosphenytoin—epilepsy syndrome	0.0133	0.0706	CrCrCtD
Cyproheptadine—Phenindamine—Oxcarbazepine—epilepsy syndrome	0.0127	0.0678	CrCrCtD
Cyproheptadine—Carbamazepine—Phenytoin—epilepsy syndrome	0.011	0.0587	CrCrCtD
Cyproheptadine—Mianserin—Oxcarbazepine—epilepsy syndrome	0.011	0.0586	CrCrCtD
Cyproheptadine—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.00938	0.0499	CrCrCtD
Cyproheptadine—Carbamazepine—Oxcarbazepine—epilepsy syndrome	0.00938	0.0499	CrCrCtD
Cyproheptadine—Phenindione—Phenytoin—epilepsy syndrome	0.0091	0.0484	CrCrCtD
Cyproheptadine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.00864	0.046	CrCrCtD
Cyproheptadine—Phenindione—Carbamazepine—epilepsy syndrome	0.0084	0.0446	CrCrCtD
Cyproheptadine—Loxapine—Clobazam—epilepsy syndrome	0.00839	0.0446	CrCrCtD
Cyproheptadine—Clozapine—Clonazepam—epilepsy syndrome	0.00788	0.0419	CrCrCtD
Cyproheptadine—Loxapine—Diazepam—epilepsy syndrome	0.0078	0.0415	CrCrCtD
Cyproheptadine—Phenindione—Oxcarbazepine—epilepsy syndrome	0.00773	0.0411	CrCrCtD
Cyproheptadine—Phenindione—Clobazam—epilepsy syndrome	0.00742	0.0394	CrCrCtD
Cyproheptadine—Chlorcyclizine—Clobazam—epilepsy syndrome	0.00721	0.0383	CrCrCtD
Cyproheptadine—Clozapine—Clobazam—epilepsy syndrome	0.00721	0.0383	CrCrCtD
Cyproheptadine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.00713	0.0379	CrCrCtD
Cyproheptadine—Clozapine—Diazepam—epilepsy syndrome	0.0067	0.0356	CrCrCtD
Cyproheptadine—Methdilazine—Carbamazepine—epilepsy syndrome	0.00631	0.0336	CrCrCtD
Cyproheptadine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.00581	0.0309	CrCrCtD
Cyproheptadine—HTR2A—phrenic nerve—epilepsy syndrome	0.00164	0.0797	CbGeAlD
Cyproheptadine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00122	0.0592	CbGeAlD
Cyproheptadine—HTR6—ganglion—epilepsy syndrome	0.000745	0.0362	CbGeAlD
Cyproheptadine—HTR2A—locus ceruleus—epilepsy syndrome	0.000731	0.0356	CbGeAlD
Cyproheptadine—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000691	0.0336	CbGeAlD
Cyproheptadine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000647	0.0315	CbGeAlD
Cyproheptadine—HTR2A—cerebellar cortex—epilepsy syndrome	0.000596	0.029	CbGeAlD
Cyproheptadine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000582	0.0283	CbGeAlD
Cyproheptadine—HTR2A—vagus nerve—epilepsy syndrome	0.00056	0.0273	CbGeAlD
Cyproheptadine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000526	0.0256	CbGeAlD
Cyproheptadine—HTR2C—ganglion—epilepsy syndrome	0.00043	0.0209	CbGeAlD
Cyproheptadine—HTR2A—pons—epilepsy syndrome	0.000421	0.0205	CbGeAlD
Cyproheptadine—HTR2A—autonomic nervous system—epilepsy syndrome	0.000389	0.0189	CbGeAlD
Cyproheptadine—HTR1A—ganglion—epilepsy syndrome	0.000362	0.0176	CbGeAlD
Cyproheptadine—SLC6A2—ganglion—epilepsy syndrome	0.000359	0.0175	CbGeAlD
Cyproheptadine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000347	0.0169	CbGeAlD
Cyproheptadine—DRD2—ganglion—epilepsy syndrome	0.000327	0.0159	CbGeAlD
Cyproheptadine—HTR6—forebrain—epilepsy syndrome	0.000312	0.0152	CbGeAlD
Cyproheptadine—HTR6—telencephalon—epilepsy syndrome	0.000287	0.014	CbGeAlD
Cyproheptadine—HTR1A—hindbrain—epilepsy syndrome	0.000275	0.0134	CbGeAlD
Cyproheptadine—DRD2—hindbrain—epilepsy syndrome	0.000248	0.0121	CbGeAlD
Cyproheptadine—HTR2A—ganglion—epilepsy syndrome	0.000216	0.0105	CbGeAlD
Cyproheptadine—CHRM2—forebrain—epilepsy syndrome	0.000187	0.00912	CbGeAlD
Cyproheptadine—HTR2C—brainstem—epilepsy syndrome	0.000187	0.0091	CbGeAlD
Cyproheptadine—HTR2C—forebrain—epilepsy syndrome	0.000181	0.00879	CbGeAlD
Cyproheptadine—HTR6—head—epilepsy syndrome	0.000179	0.00871	CbGeAlD
Cyproheptadine—CHRM2—telencephalon—epilepsy syndrome	0.000172	0.00838	CbGeAlD
Cyproheptadine—CHRM1—forebrain—epilepsy syndrome	0.00017	0.0083	CbGeAlD
Cyproheptadine—HTR6—nervous system—epilepsy syndrome	0.00017	0.00825	CbGeAlD
Cyproheptadine—HTR2B—forebrain—epilepsy syndrome	0.00017	0.00825	CbGeAlD
Cyproheptadine—HTR2C—telencephalon—epilepsy syndrome	0.000166	0.00808	CbGeAlD
Cyproheptadine—HTR2A—hindbrain—epilepsy syndrome	0.000164	0.00797	CbGeAlD
Cyproheptadine—HTR6—central nervous system—epilepsy syndrome	0.000163	0.00795	CbGeAlD
Cyproheptadine—HTR1A—brainstem—epilepsy syndrome	0.000157	0.00766	CbGeAlD
Cyproheptadine—CHRM1—telencephalon—epilepsy syndrome	0.000157	0.00763	CbGeAlD
Cyproheptadine—SLC6A2—brainstem—epilepsy syndrome	0.000156	0.0076	CbGeAlD
Cyproheptadine—HTR2B—telencephalon—epilepsy syndrome	0.000156	0.00759	CbGeAlD
Cyproheptadine—CHRM3—forebrain—epilepsy syndrome	0.000153	0.00743	CbGeAlD
Cyproheptadine—HTR1A—forebrain—epilepsy syndrome	0.000152	0.0074	CbGeAlD
Cyproheptadine—SLC6A2—forebrain—epilepsy syndrome	0.000151	0.00733	CbGeAlD
Cyproheptadine—DRD2—brainstem—epilepsy syndrome	0.000142	0.00692	CbGeAlD
Cyproheptadine—CHRM3—telencephalon—epilepsy syndrome	0.00014	0.00683	CbGeAlD
Cyproheptadine—HTR1A—telencephalon—epilepsy syndrome	0.00014	0.0068	CbGeAlD
Cyproheptadine—SLC6A2—telencephalon—epilepsy syndrome	0.000139	0.00674	CbGeAlD
Cyproheptadine—DRD2—forebrain—epilepsy syndrome	0.000137	0.00668	CbGeAlD
Cyproheptadine—HTR2C—medulla oblongata—epilepsy syndrome	0.00013	0.00635	CbGeAlD
Cyproheptadine—HTR6—brain—epilepsy syndrome	0.00013	0.00631	CbGeAlD
Cyproheptadine—DRD2—telencephalon—epilepsy syndrome	0.000126	0.00615	CbGeAlD
Cyproheptadine—HTR2C—midbrain—epilepsy syndrome	0.000119	0.0058	CbGeAlD
Cyproheptadine—HTR2C—spinal cord—epilepsy syndrome	0.000116	0.00566	CbGeAlD
Cyproheptadine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000109	0.0053	CbGeAlD
Cyproheptadine—HRH1—forebrain—epilepsy syndrome	0.000108	0.00528	CbGeAlD
Cyproheptadine—CHRM2—head—epilepsy syndrome	0.000107	0.00522	CbGeAlD
Cyproheptadine—HTR2C—head—epilepsy syndrome	0.000103	0.00503	CbGeAlD
Cyproheptadine—CHRM2—nervous system—epilepsy syndrome	0.000102	0.00495	CbGeAlD
Cyproheptadine—HTR1A—midbrain—epilepsy syndrome	0.0001	0.00488	CbGeAlD
Cyproheptadine—HRH1—telencephalon—epilepsy syndrome	9.97e-05	0.00485	CbGeAlD
Cyproheptadine—HTR2C—nervous system—epilepsy syndrome	9.8e-05	0.00477	CbGeAlD
Cyproheptadine—HTR1A—spinal cord—epilepsy syndrome	9.79e-05	0.00476	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—epilepsy syndrome	9.79e-05	0.00476	CbGeAlD
Cyproheptadine—CHRM1—head—epilepsy syndrome	9.76e-05	0.00475	CbGeAlD
Cyproheptadine—HTR2B—head—epilepsy syndrome	9.71e-05	0.00473	CbGeAlD
Cyproheptadine—HTR2C—central nervous system—epilepsy syndrome	9.44e-05	0.00459	CbGeAlD
Cyproheptadine—HTR2A—brainstem—epilepsy syndrome	9.38e-05	0.00457	CbGeAlD
Cyproheptadine—CHRM1—nervous system—epilepsy syndrome	9.26e-05	0.0045	CbGeAlD
Cyproheptadine—HTR2B—nervous system—epilepsy syndrome	9.21e-05	0.00448	CbGeAlD
Cyproheptadine—DRD2—midbrain—epilepsy syndrome	9.07e-05	0.00441	CbGeAlD
Cyproheptadine—HTR2A—forebrain—epilepsy syndrome	9.06e-05	0.00441	CbGeAlD
Cyproheptadine—CHRM1—central nervous system—epilepsy syndrome	8.91e-05	0.00434	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—epilepsy syndrome	8.86e-05	0.00431	CbGeAlD
Cyproheptadine—CHRM3—head—epilepsy syndrome	8.74e-05	0.00425	CbGeAlD
Cyproheptadine—HTR1A—head—epilepsy syndrome	8.7e-05	0.00423	CbGeAlD
Cyproheptadine—SLC6A2—head—epilepsy syndrome	8.63e-05	0.0042	CbGeAlD
Cyproheptadine—Carbamazepine—SCN9A—epilepsy syndrome	8.51e-05	0.0554	CrCbGaD
Cyproheptadine—HTR2A—telencephalon—epilepsy syndrome	8.33e-05	0.00405	CbGeAlD
Cyproheptadine—CHRM3—nervous system—epilepsy syndrome	8.28e-05	0.00403	CbGeAlD
Cyproheptadine—HTR1A—nervous system—epilepsy syndrome	8.25e-05	0.00402	CbGeAlD
Cyproheptadine—SLC6A2—nervous system—epilepsy syndrome	8.18e-05	0.00398	CbGeAlD
Cyproheptadine—CHRM3—central nervous system—epilepsy syndrome	7.97e-05	0.00388	CbGeAlD
Cyproheptadine—HTR1A—central nervous system—epilepsy syndrome	7.94e-05	0.00387	CbGeAlD
Cyproheptadine—Amitriptyline—KCND2—epilepsy syndrome	7.93e-05	0.0516	CrCbGaD
Cyproheptadine—SLC6A2—central nervous system—epilepsy syndrome	7.88e-05	0.00383	CbGeAlD
Cyproheptadine—DRD2—head—epilepsy syndrome	7.86e-05	0.00383	CbGeAlD
Cyproheptadine—Carbamazepine—SCN4A—epilepsy syndrome	7.82e-05	0.0509	CrCbGaD
Cyproheptadine—CHRM2—brain—epilepsy syndrome	7.77e-05	0.00378	CbGeAlD
Cyproheptadine—HTR1A—cerebellum—epilepsy syndrome	7.76e-05	0.00378	CbGeAlD
Cyproheptadine—HTR2C—brain—epilepsy syndrome	7.49e-05	0.00365	CbGeAlD
Cyproheptadine—DRD2—nervous system—epilepsy syndrome	7.45e-05	0.00363	CbGeAlD
Cyproheptadine—Amitriptyline—KCNQ3—epilepsy syndrome	7.37e-05	0.048	CrCbGaD
Cyproheptadine—Amitriptyline—KCNQ2—epilepsy syndrome	7.37e-05	0.048	CrCbGaD
Cyproheptadine—DRD2—central nervous system—epilepsy syndrome	7.18e-05	0.00349	CbGeAlD
Cyproheptadine—CHRM1—brain—epilepsy syndrome	7.07e-05	0.00344	CbGeAlD
Cyproheptadine—HTR2B—brain—epilepsy syndrome	7.04e-05	0.00342	CbGeAlD
Cyproheptadine—DRD2—cerebellum—epilepsy syndrome	7.01e-05	0.00341	CbGeAlD
Cyproheptadine—HTR2A—medulla oblongata—epilepsy syndrome	6.54e-05	0.00318	CbGeAlD
Cyproheptadine—CHRM3—brain—epilepsy syndrome	6.33e-05	0.00308	CbGeAlD
Cyproheptadine—HTR1A—brain—epilepsy syndrome	6.31e-05	0.00307	CbGeAlD
Cyproheptadine—Amitriptyline—NTRK2—epilepsy syndrome	6.27e-05	0.0408	CrCbGaD
Cyproheptadine—SLC6A2—brain—epilepsy syndrome	6.25e-05	0.00304	CbGeAlD
Cyproheptadine—HRH1—head—epilepsy syndrome	6.21e-05	0.00302	CbGeAlD
Cyproheptadine—Metixene—CHRM3—epilepsy syndrome	6.12e-05	0.0399	CrCbGaD
Cyproheptadine—HTR2A—midbrain—epilepsy syndrome	5.98e-05	0.00291	CbGeAlD
Cyproheptadine—HRH1—nervous system—epilepsy syndrome	5.89e-05	0.00286	CbGeAlD
Cyproheptadine—HTR2A—spinal cord—epilepsy syndrome	5.83e-05	0.00284	CbGeAlD
Cyproheptadine—Metixene—CHRM1—epilepsy syndrome	5.71e-05	0.0372	CrCbGaD
Cyproheptadine—DRD2—brain—epilepsy syndrome	5.7e-05	0.00277	CbGeAlD
Cyproheptadine—HRH1—central nervous system—epilepsy syndrome	5.67e-05	0.00276	CbGeAlD
Cyproheptadine—HTR2A—head—epilepsy syndrome	5.19e-05	0.00252	CbGeAlD
Cyproheptadine—HTR2A—nervous system—epilepsy syndrome	4.92e-05	0.00239	CbGeAlD
Cyproheptadine—HTR2A—central nervous system—epilepsy syndrome	4.73e-05	0.0023	CbGeAlD
Cyproheptadine—Metixene—CHRM2—epilepsy syndrome	4.66e-05	0.0304	CrCbGaD
Cyproheptadine—HTR2A—cerebellum—epilepsy syndrome	4.63e-05	0.00225	CbGeAlD
Cyproheptadine—HRH1—brain—epilepsy syndrome	4.5e-05	0.00219	CbGeAlD
Cyproheptadine—Protriptyline—SLC6A4—epilepsy syndrome	4.07e-05	0.0265	CrCbGaD
Cyproheptadine—Clozapine—HRH3—epilepsy syndrome	3.92e-05	0.0255	CrCbGaD
Cyproheptadine—HTR2A—brain—epilepsy syndrome	3.76e-05	0.00183	CbGeAlD
Cyproheptadine—Dyspepsia—Lamotrigine—epilepsy syndrome	3.54e-05	0.000634	CcSEcCtD
Cyproheptadine—Vertigo—Valproic Acid—epilepsy syndrome	3.52e-05	0.00063	CcSEcCtD
Cyproheptadine—Leukopenia—Valproic Acid—epilepsy syndrome	3.51e-05	0.000627	CcSEcCtD
Cyproheptadine—Asthenia—Vigabatrin—epilepsy syndrome	3.51e-05	0.000627	CcSEcCtD
Cyproheptadine—Decreased appetite—Lamotrigine—epilepsy syndrome	3.5e-05	0.000626	CcSEcCtD
Cyproheptadine—Urticaria—Clonazepam—epilepsy syndrome	3.49e-05	0.000624	CcSEcCtD
Cyproheptadine—Tinnitus—Gabapentin—epilepsy syndrome	3.48e-05	0.000622	CcSEcCtD
Cyproheptadine—Dizziness—Midazolam—epilepsy syndrome	3.48e-05	0.000622	CcSEcCtD
Cyproheptadine—Tension—Pregabalin—epilepsy syndrome	3.48e-05	0.000622	CcSEcCtD
Cyproheptadine—Fatigue—Lamotrigine—epilepsy syndrome	3.47e-05	0.000621	CcSEcCtD
Cyproheptadine—Urticaria—Phenytoin—epilepsy syndrome	3.47e-05	0.00062	CcSEcCtD
Cyproheptadine—Palpitations—Valproic Acid—epilepsy syndrome	3.46e-05	0.000619	CcSEcCtD
Cyproheptadine—Asthenia—Diazepam—epilepsy syndrome	3.45e-05	0.000617	CcSEcCtD
Cyproheptadine—Urticaria—Oxcarbazepine—epilepsy syndrome	3.45e-05	0.000617	CcSEcCtD
Cyproheptadine—Constipation—Lamotrigine—epilepsy syndrome	3.44e-05	0.000616	CcSEcCtD
Cyproheptadine—Nervousness—Pregabalin—epilepsy syndrome	3.44e-05	0.000616	CcSEcCtD
Cyproheptadine—Nausea—Acetazolamide—epilepsy syndrome	3.44e-05	0.000615	CcSEcCtD
Cyproheptadine—Dizziness—Levetiracetam—epilepsy syndrome	3.44e-05	0.000614	CcSEcCtD
Cyproheptadine—Feeling abnormal—Carbamazepine—epilepsy syndrome	3.43e-05	0.000614	CcSEcCtD
Cyproheptadine—Diarrhoea—Fosphenytoin—epilepsy syndrome	3.43e-05	0.000614	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Topiramate—epilepsy syndrome	3.43e-05	0.000613	CcSEcCtD
Cyproheptadine—Vomiting—Propofol—epilepsy syndrome	3.42e-05	0.000611	CcSEcCtD
Cyproheptadine—Rash—Propofol—epilepsy syndrome	3.39e-05	0.000606	CcSEcCtD
Cyproheptadine—Dermatitis—Propofol—epilepsy syndrome	3.39e-05	0.000606	CcSEcCtD
Cyproheptadine—Headache—Propofol—epilepsy syndrome	3.37e-05	0.000602	CcSEcCtD
Cyproheptadine—Chills—Gabapentin—epilepsy syndrome	3.35e-05	0.000599	CcSEcCtD
Cyproheptadine—Vomiting—Midazolam—epilepsy syndrome	3.34e-05	0.000598	CcSEcCtD
Cyproheptadine—Diarrhoea—Vigabatrin—epilepsy syndrome	3.34e-05	0.000598	CcSEcCtD
Cyproheptadine—Asthenia—Felbamate—epilepsy syndrome	3.34e-05	0.000598	CcSEcCtD
Cyproheptadine—Vision blurred—Pregabalin—epilepsy syndrome	3.34e-05	0.000597	CcSEcCtD
Cyproheptadine—Tremor—Pregabalin—epilepsy syndrome	3.32e-05	0.000594	CcSEcCtD
Cyproheptadine—Feeling abnormal—Lamotrigine—epilepsy syndrome	3.32e-05	0.000593	CcSEcCtD
Cyproheptadine—Rash—Midazolam—epilepsy syndrome	3.32e-05	0.000593	CcSEcCtD
Cyproheptadine—Dizziness—Fosphenytoin—epilepsy syndrome	3.32e-05	0.000593	CcSEcCtD
Cyproheptadine—Dermatitis—Midazolam—epilepsy syndrome	3.31e-05	0.000593	CcSEcCtD
Cyproheptadine—Urticaria—Carbamazepine—epilepsy syndrome	3.31e-05	0.000592	CcSEcCtD
Cyproheptadine—Vomiting—Levetiracetam—epilepsy syndrome	3.3e-05	0.000591	CcSEcCtD
Cyproheptadine—Headache—Midazolam—epilepsy syndrome	3.3e-05	0.000589	CcSEcCtD
Cyproheptadine—Diarrhoea—Diazepam—epilepsy syndrome	3.29e-05	0.000589	CcSEcCtD
Cyproheptadine—Rash—Levetiracetam—epilepsy syndrome	3.28e-05	0.000586	CcSEcCtD
Cyproheptadine—Dermatitis—Levetiracetam—epilepsy syndrome	3.27e-05	0.000585	CcSEcCtD
Cyproheptadine—Asthenia—Zonisamide—epilepsy syndrome	3.27e-05	0.000585	CcSEcCtD
Cyproheptadine—Agranulocytosis—Topiramate—epilepsy syndrome	3.26e-05	0.000584	CcSEcCtD
Cyproheptadine—Agitation—Pregabalin—epilepsy syndrome	3.26e-05	0.000582	CcSEcCtD
Cyproheptadine—Headache—Levetiracetam—epilepsy syndrome	3.25e-05	0.000582	CcSEcCtD
Cyproheptadine—Dizziness—Vigabatrin—epilepsy syndrome	3.23e-05	0.000578	CcSEcCtD
Cyproheptadine—Confusional state—Valproic Acid—epilepsy syndrome	3.23e-05	0.000577	CcSEcCtD
Cyproheptadine—Oedema—Valproic Acid—epilepsy syndrome	3.2e-05	0.000572	CcSEcCtD
Cyproheptadine—Urticaria—Lamotrigine—epilepsy syndrome	3.2e-05	0.000572	CcSEcCtD
Cyproheptadine—Nausea—Propofol—epilepsy syndrome	3.19e-05	0.000571	CcSEcCtD
Cyproheptadine—Tension—Gabapentin—epilepsy syndrome	3.19e-05	0.00057	CcSEcCtD
Cyproheptadine—Vomiting—Fosphenytoin—epilepsy syndrome	3.19e-05	0.00057	CcSEcCtD
Cyproheptadine—Diarrhoea—Felbamate—epilepsy syndrome	3.19e-05	0.00057	CcSEcCtD
Cyproheptadine—Vertigo—Pregabalin—epilepsy syndrome	3.18e-05	0.000569	CcSEcCtD
Cyproheptadine—Dizziness—Diazepam—epilepsy syndrome	3.18e-05	0.000569	CcSEcCtD
Cyproheptadine—Syncope—Pregabalin—epilepsy syndrome	3.18e-05	0.000568	CcSEcCtD
Cyproheptadine—Leukopenia—Pregabalin—epilepsy syndrome	3.17e-05	0.000567	CcSEcCtD
Cyproheptadine—Rash—Fosphenytoin—epilepsy syndrome	3.16e-05	0.000565	CcSEcCtD
Cyproheptadine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.16e-05	0.000565	CcSEcCtD
Cyproheptadine—Nervousness—Gabapentin—epilepsy syndrome	3.16e-05	0.000564	CcSEcCtD
Cyproheptadine—Asthenia—Clonazepam—epilepsy syndrome	3.15e-05	0.000564	CcSEcCtD
Cyproheptadine—Nortriptyline—CHRM3—epilepsy syndrome	3.14e-05	0.0205	CrCbGaD
Cyproheptadine—Headache—Fosphenytoin—epilepsy syndrome	3.14e-05	0.000562	CcSEcCtD
Cyproheptadine—Hepatitis—Topiramate—epilepsy syndrome	3.14e-05	0.000562	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.13e-05	0.00056	CcSEcCtD
Cyproheptadine—Palpitations—Pregabalin—epilepsy syndrome	3.13e-05	0.00056	CcSEcCtD
Cyproheptadine—Asthenia—Phenytoin—epilepsy syndrome	3.13e-05	0.00056	CcSEcCtD
Cyproheptadine—Nausea—Midazolam—epilepsy syndrome	3.12e-05	0.000559	CcSEcCtD
Cyproheptadine—Hallucination—Topiramate—epilepsy syndrome	3.12e-05	0.000559	CcSEcCtD
Cyproheptadine—Tachycardia—Valproic Acid—epilepsy syndrome	3.12e-05	0.000558	CcSEcCtD
Cyproheptadine—Diarrhoea—Zonisamide—epilepsy syndrome	3.12e-05	0.000558	CcSEcCtD
Cyproheptadine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.11e-05	0.000557	CcSEcCtD
Cyproheptadine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.11e-05	0.000557	CcSEcCtD
Cyproheptadine—Vomiting—Vigabatrin—epilepsy syndrome	3.11e-05	0.000556	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.09e-05	0.000553	CcSEcCtD
Cyproheptadine—Nausea—Levetiracetam—epilepsy syndrome	3.09e-05	0.000552	CcSEcCtD
Cyproheptadine—Rash—Vigabatrin—epilepsy syndrome	3.08e-05	0.000551	CcSEcCtD
Cyproheptadine—Dizziness—Felbamate—epilepsy syndrome	3.08e-05	0.000551	CcSEcCtD
Cyproheptadine—Dermatitis—Vigabatrin—epilepsy syndrome	3.08e-05	0.000551	CcSEcCtD
Cyproheptadine—Convulsion—Pregabalin—epilepsy syndrome	3.07e-05	0.000549	CcSEcCtD
Cyproheptadine—Vision blurred—Gabapentin—epilepsy syndrome	3.06e-05	0.000548	CcSEcCtD
Cyproheptadine—Headache—Vigabatrin—epilepsy syndrome	3.06e-05	0.000548	CcSEcCtD
Cyproheptadine—Vomiting—Diazepam—epilepsy syndrome	3.06e-05	0.000547	CcSEcCtD
Cyproheptadine—Anorexia—Valproic Acid—epilepsy syndrome	3.05e-05	0.000545	CcSEcCtD
Cyproheptadine—Tremor—Gabapentin—epilepsy syndrome	3.04e-05	0.000544	CcSEcCtD
Cyproheptadine—Rash—Diazepam—epilepsy syndrome	3.03e-05	0.000543	CcSEcCtD
Cyproheptadine—Dermatitis—Diazepam—epilepsy syndrome	3.03e-05	0.000542	CcSEcCtD
Cyproheptadine—Dizziness—Zonisamide—epilepsy syndrome	3.01e-05	0.000539	CcSEcCtD
Cyproheptadine—Headache—Diazepam—epilepsy syndrome	3.01e-05	0.000539	CcSEcCtD
Cyproheptadine—Diarrhoea—Clonazepam—epilepsy syndrome	3.01e-05	0.000538	CcSEcCtD
Cyproheptadine—Hypotension—Valproic Acid—epilepsy syndrome	2.99e-05	0.000535	CcSEcCtD
Cyproheptadine—Asthenia—Carbamazepine—epilepsy syndrome	2.99e-05	0.000534	CcSEcCtD
Cyproheptadine—Agitation—Gabapentin—epilepsy syndrome	2.99e-05	0.000534	CcSEcCtD
Cyproheptadine—Diarrhoea—Phenytoin—epilepsy syndrome	2.99e-05	0.000534	CcSEcCtD
Cyproheptadine—Nausea—Fosphenytoin—epilepsy syndrome	2.98e-05	0.000533	CcSEcCtD
Cyproheptadine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.000531	CcSEcCtD
Cyproheptadine—Vomiting—Felbamate—epilepsy syndrome	2.96e-05	0.00053	CcSEcCtD
Cyproheptadine—Rash—Felbamate—epilepsy syndrome	2.94e-05	0.000525	CcSEcCtD
Cyproheptadine—Dermatitis—Felbamate—epilepsy syndrome	2.93e-05	0.000525	CcSEcCtD
Cyproheptadine—Nortriptyline—CHRM1—epilepsy syndrome	2.93e-05	0.0191	CrCbGaD
Cyproheptadine—Tinnitus—Topiramate—epilepsy syndrome	2.93e-05	0.000524	CcSEcCtD
Cyproheptadine—Vertigo—Gabapentin—epilepsy syndrome	2.92e-05	0.000522	CcSEcCtD
Cyproheptadine—Headache—Felbamate—epilepsy syndrome	2.92e-05	0.000522	CcSEcCtD
Cyproheptadine—Confusional state—Pregabalin—epilepsy syndrome	2.92e-05	0.000522	CcSEcCtD
Cyproheptadine—Syncope—Gabapentin—epilepsy syndrome	2.91e-05	0.000521	CcSEcCtD
Cyproheptadine—Leukopenia—Gabapentin—epilepsy syndrome	2.91e-05	0.00052	CcSEcCtD
Cyproheptadine—Dizziness—Clonazepam—epilepsy syndrome	2.9e-05	0.00052	CcSEcCtD
Cyproheptadine—Nausea—Vigabatrin—epilepsy syndrome	2.9e-05	0.000519	CcSEcCtD
Cyproheptadine—Vomiting—Zonisamide—epilepsy syndrome	2.9e-05	0.000518	CcSEcCtD
Cyproheptadine—Insomnia—Valproic Acid—epilepsy syndrome	2.89e-05	0.000517	CcSEcCtD
Cyproheptadine—Oedema—Pregabalin—epilepsy syndrome	2.89e-05	0.000517	CcSEcCtD
Cyproheptadine—Asthenia—Lamotrigine—epilepsy syndrome	2.89e-05	0.000517	CcSEcCtD
Cyproheptadine—Dizziness—Phenytoin—epilepsy syndrome	2.89e-05	0.000516	CcSEcCtD
Cyproheptadine—Rash—Zonisamide—epilepsy syndrome	2.87e-05	0.000514	CcSEcCtD
Cyproheptadine—Paraesthesia—Valproic Acid—epilepsy syndrome	2.87e-05	0.000514	CcSEcCtD
Cyproheptadine—Palpitations—Gabapentin—epilepsy syndrome	2.87e-05	0.000514	CcSEcCtD
Cyproheptadine—Dermatitis—Zonisamide—epilepsy syndrome	2.87e-05	0.000514	CcSEcCtD
Cyproheptadine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.87e-05	0.000513	CcSEcCtD
Cyproheptadine—Protriptyline—CYP2D6—epilepsy syndrome	2.86e-05	0.0186	CrCbGaD
Cyproheptadine—Nausea—Diazepam—epilepsy syndrome	2.86e-05	0.000511	CcSEcCtD
Cyproheptadine—Loss of consciousness—Gabapentin—epilepsy syndrome	2.86e-05	0.000511	CcSEcCtD
Cyproheptadine—Headache—Zonisamide—epilepsy syndrome	2.86e-05	0.000511	CcSEcCtD
Cyproheptadine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.85e-05	0.00051	CcSEcCtD
Cyproheptadine—Shock—Pregabalin—epilepsy syndrome	2.85e-05	0.000509	CcSEcCtD
Cyproheptadine—Somnolence—Valproic Acid—epilepsy syndrome	2.84e-05	0.000509	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.83e-05	0.000506	CcSEcCtD
Cyproheptadine—Tachycardia—Pregabalin—epilepsy syndrome	2.82e-05	0.000505	CcSEcCtD
Cyproheptadine—Chills—Topiramate—epilepsy syndrome	2.82e-05	0.000504	CcSEcCtD
Cyproheptadine—Dyspepsia—Valproic Acid—epilepsy syndrome	2.82e-05	0.000504	CcSEcCtD
Cyproheptadine—Convulsion—Gabapentin—epilepsy syndrome	2.82e-05	0.000504	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.8e-05	0.0005	CcSEcCtD
Cyproheptadine—Loxapine—CHRM3—epilepsy syndrome	2.79e-05	0.0182	CrCbGaD
Cyproheptadine—Vomiting—Clonazepam—epilepsy syndrome	2.79e-05	0.0005	CcSEcCtD
Cyproheptadine—Decreased appetite—Valproic Acid—epilepsy syndrome	2.78e-05	0.000497	CcSEcCtD
Cyproheptadine—Vomiting—Phenytoin—epilepsy syndrome	2.77e-05	0.000496	CcSEcCtD
Cyproheptadine—Rash—Clonazepam—epilepsy syndrome	2.77e-05	0.000495	CcSEcCtD
Cyproheptadine—Dermatitis—Clonazepam—epilepsy syndrome	2.77e-05	0.000495	CcSEcCtD
Cyproheptadine—Nausea—Felbamate—epilepsy syndrome	2.77e-05	0.000495	CcSEcCtD
Cyproheptadine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.76e-05	0.000494	CcSEcCtD
Cyproheptadine—Fatigue—Valproic Acid—epilepsy syndrome	2.76e-05	0.000493	CcSEcCtD
Cyproheptadine—Anorexia—Pregabalin—epilepsy syndrome	2.76e-05	0.000493	CcSEcCtD
Cyproheptadine—Dizziness—Carbamazepine—epilepsy syndrome	2.75e-05	0.000493	CcSEcCtD
Cyproheptadine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.75e-05	0.000493	CcSEcCtD
Cyproheptadine—Headache—Clonazepam—epilepsy syndrome	2.75e-05	0.000492	CcSEcCtD
Cyproheptadine—Rash—Phenytoin—epilepsy syndrome	2.75e-05	0.000492	CcSEcCtD
Cyproheptadine—Dermatitis—Phenytoin—epilepsy syndrome	2.75e-05	0.000492	CcSEcCtD
Cyproheptadine—Rash—Oxcarbazepine—epilepsy syndrome	2.74e-05	0.000489	CcSEcCtD
Cyproheptadine—Constipation—Valproic Acid—epilepsy syndrome	2.74e-05	0.000489	CcSEcCtD
Cyproheptadine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.73e-05	0.000489	CcSEcCtD
Cyproheptadine—Headache—Phenytoin—epilepsy syndrome	2.73e-05	0.000489	CcSEcCtD
Cyproheptadine—Headache—Oxcarbazepine—epilepsy syndrome	2.72e-05	0.000486	CcSEcCtD
Cyproheptadine—Nausea—Zonisamide—epilepsy syndrome	2.71e-05	0.000484	CcSEcCtD
Cyproheptadine—Hypotension—Pregabalin—epilepsy syndrome	2.7e-05	0.000483	CcSEcCtD
Cyproheptadine—Tension—Topiramate—epilepsy syndrome	2.68e-05	0.00048	CcSEcCtD
Cyproheptadine—Confusional state—Gabapentin—epilepsy syndrome	2.67e-05	0.000478	CcSEcCtD
Cyproheptadine—Mianserin—HTR7—epilepsy syndrome	2.67e-05	0.0174	CrCbGaD
Cyproheptadine—Dizziness—Lamotrigine—epilepsy syndrome	2.66e-05	0.000476	CcSEcCtD
Cyproheptadine—Nervousness—Topiramate—epilepsy syndrome	2.65e-05	0.000475	CcSEcCtD
Cyproheptadine—Oedema—Gabapentin—epilepsy syndrome	2.65e-05	0.000474	CcSEcCtD
Cyproheptadine—Vomiting—Carbamazepine—epilepsy syndrome	2.65e-05	0.000474	CcSEcCtD
Cyproheptadine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.64e-05	0.000471	CcSEcCtD
Cyproheptadine—Rash—Carbamazepine—epilepsy syndrome	2.63e-05	0.00047	CcSEcCtD
Cyproheptadine—Dermatitis—Carbamazepine—epilepsy syndrome	2.62e-05	0.000469	CcSEcCtD
Cyproheptadine—Insomnia—Pregabalin—epilepsy syndrome	2.62e-05	0.000468	CcSEcCtD
Cyproheptadine—Nausea—Clonazepam—epilepsy syndrome	2.61e-05	0.000467	CcSEcCtD
Cyproheptadine—Headache—Carbamazepine—epilepsy syndrome	2.61e-05	0.000467	CcSEcCtD
Cyproheptadine—Shock—Gabapentin—epilepsy syndrome	2.61e-05	0.000467	CcSEcCtD
Cyproheptadine—Loxapine—CHRM1—epilepsy syndrome	2.61e-05	0.017	CrCbGaD
Cyproheptadine—Paraesthesia—Pregabalin—epilepsy syndrome	2.6e-05	0.000464	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.6e-05	0.000464	CcSEcCtD
Cyproheptadine—Nausea—Phenytoin—epilepsy syndrome	2.59e-05	0.000464	CcSEcCtD
Cyproheptadine—Tachycardia—Gabapentin—epilepsy syndrome	2.59e-05	0.000463	CcSEcCtD
Cyproheptadine—Carbamazepine—ABCC2—epilepsy syndrome	2.58e-05	0.0168	CrCbGaD
Cyproheptadine—Nausea—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000461	CcSEcCtD
Cyproheptadine—Vision blurred—Topiramate—epilepsy syndrome	2.58e-05	0.000461	CcSEcCtD
Cyproheptadine—Somnolence—Pregabalin—epilepsy syndrome	2.57e-05	0.00046	CcSEcCtD
Cyproheptadine—Amitriptyline—OPRD1—epilepsy syndrome	2.57e-05	0.0167	CrCbGaD
Cyproheptadine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.56e-05	0.000459	CcSEcCtD
Cyproheptadine—Tremor—Topiramate—epilepsy syndrome	2.56e-05	0.000458	CcSEcCtD
Cyproheptadine—Vomiting—Lamotrigine—epilepsy syndrome	2.56e-05	0.000458	CcSEcCtD
Cyproheptadine—Urticaria—Valproic Acid—epilepsy syndrome	2.54e-05	0.000455	CcSEcCtD
Cyproheptadine—Rash—Lamotrigine—epilepsy syndrome	2.54e-05	0.000454	CcSEcCtD
Cyproheptadine—Dermatitis—Lamotrigine—epilepsy syndrome	2.54e-05	0.000454	CcSEcCtD
Cyproheptadine—Anorexia—Gabapentin—epilepsy syndrome	2.53e-05	0.000452	CcSEcCtD
Cyproheptadine—Headache—Lamotrigine—epilepsy syndrome	2.52e-05	0.000451	CcSEcCtD
Cyproheptadine—Decreased appetite—Pregabalin—epilepsy syndrome	2.51e-05	0.00045	CcSEcCtD
Cyproheptadine—Agitation—Topiramate—epilepsy syndrome	2.51e-05	0.000449	CcSEcCtD
Cyproheptadine—Fatigue—Pregabalin—epilepsy syndrome	2.49e-05	0.000446	CcSEcCtD
Cyproheptadine—Hypotension—Gabapentin—epilepsy syndrome	2.48e-05	0.000443	CcSEcCtD
Cyproheptadine—Nausea—Carbamazepine—epilepsy syndrome	2.47e-05	0.000443	CcSEcCtD
Cyproheptadine—Constipation—Pregabalin—epilepsy syndrome	2.47e-05	0.000442	CcSEcCtD
Cyproheptadine—Vertigo—Topiramate—epilepsy syndrome	2.46e-05	0.000439	CcSEcCtD
Cyproheptadine—Syncope—Topiramate—epilepsy syndrome	2.45e-05	0.000438	CcSEcCtD
Cyproheptadine—Leukopenia—Topiramate—epilepsy syndrome	2.45e-05	0.000438	CcSEcCtD
Cyproheptadine—Palpitations—Topiramate—epilepsy syndrome	2.42e-05	0.000432	CcSEcCtD
Cyproheptadine—Loss of consciousness—Topiramate—epilepsy syndrome	2.4e-05	0.00043	CcSEcCtD
Cyproheptadine—Insomnia—Gabapentin—epilepsy syndrome	2.4e-05	0.000429	CcSEcCtD
Cyproheptadine—Nortriptyline—CHRM2—epilepsy syndrome	2.39e-05	0.0156	CrCbGaD
Cyproheptadine—Nausea—Lamotrigine—epilepsy syndrome	2.39e-05	0.000428	CcSEcCtD
Cyproheptadine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.38e-05	0.000426	CcSEcCtD
Cyproheptadine—Paraesthesia—Gabapentin—epilepsy syndrome	2.38e-05	0.000426	CcSEcCtD
Cyproheptadine—Convulsion—Topiramate—epilepsy syndrome	2.37e-05	0.000424	CcSEcCtD
Cyproheptadine—Somnolence—Gabapentin—epilepsy syndrome	2.36e-05	0.000422	CcSEcCtD
Cyproheptadine—Clozapine—CHRM3—epilepsy syndrome	2.35e-05	0.0153	CrCbGaD
Cyproheptadine—Dyspepsia—Gabapentin—epilepsy syndrome	2.33e-05	0.000417	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—HTR2A—epilepsy syndrome	2.33e-05	0.0152	CrCbGaD
Cyproheptadine—Decreased appetite—Gabapentin—epilepsy syndrome	2.31e-05	0.000412	CcSEcCtD
Cyproheptadine—Urticaria—Pregabalin—epilepsy syndrome	2.3e-05	0.000411	CcSEcCtD
Cyproheptadine—Asthenia—Valproic Acid—epilepsy syndrome	2.29e-05	0.00041	CcSEcCtD
Cyproheptadine—Fatigue—Gabapentin—epilepsy syndrome	2.29e-05	0.000409	CcSEcCtD
Cyproheptadine—Mianserin—ADRA2A—epilepsy syndrome	2.29e-05	0.0149	CrCbGaD
Cyproheptadine—Constipation—Gabapentin—epilepsy syndrome	2.27e-05	0.000406	CcSEcCtD
Cyproheptadine—Confusional state—Topiramate—epilepsy syndrome	2.25e-05	0.000402	CcSEcCtD
Cyproheptadine—Oedema—Topiramate—epilepsy syndrome	2.23e-05	0.000399	CcSEcCtD
Cyproheptadine—Shock—Topiramate—epilepsy syndrome	2.19e-05	0.000393	CcSEcCtD
Cyproheptadine—Diarrhoea—Valproic Acid—epilepsy syndrome	2.19e-05	0.000391	CcSEcCtD
Cyproheptadine—Clozapine—CHRM1—epilepsy syndrome	2.19e-05	0.0142	CrCbGaD
Cyproheptadine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.19e-05	0.000391	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Topiramate—epilepsy syndrome	2.18e-05	0.000391	CcSEcCtD
Cyproheptadine—Amitriptyline—CHRM3—epilepsy syndrome	2.18e-05	0.0142	CrCbGaD
Cyproheptadine—Tachycardia—Topiramate—epilepsy syndrome	2.18e-05	0.000389	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.16e-05	0.000386	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	2.13e-05	0.0139	CrCbGaD
Cyproheptadine—Loxapine—CHRM2—epilepsy syndrome	2.13e-05	0.0139	CrCbGaD
Cyproheptadine—Anorexia—Topiramate—epilepsy syndrome	2.13e-05	0.00038	CcSEcCtD
Cyproheptadine—Loxapine—HTR7—epilepsy syndrome	2.12e-05	0.0138	CrCbGaD
Cyproheptadine—Dizziness—Valproic Acid—epilepsy syndrome	2.12e-05	0.000378	CcSEcCtD
Cyproheptadine—Urticaria—Gabapentin—epilepsy syndrome	2.11e-05	0.000377	CcSEcCtD
Cyproheptadine—Hypotension—Topiramate—epilepsy syndrome	2.08e-05	0.000373	CcSEcCtD
Cyproheptadine—Asthenia—Pregabalin—epilepsy syndrome	2.07e-05	0.000371	CcSEcCtD
Cyproheptadine—Protriptyline—ABCB1—epilepsy syndrome	2.04e-05	0.0133	CrCbGaD
Cyproheptadine—Amitriptyline—CHRM1—epilepsy syndrome	2.03e-05	0.0132	CrCbGaD
Cyproheptadine—Vomiting—Valproic Acid—epilepsy syndrome	2.03e-05	0.000364	CcSEcCtD
Cyproheptadine—Insomnia—Topiramate—epilepsy syndrome	2.02e-05	0.000361	CcSEcCtD
Cyproheptadine—Rash—Valproic Acid—epilepsy syndrome	2.02e-05	0.000361	CcSEcCtD
Cyproheptadine—Dermatitis—Valproic Acid—epilepsy syndrome	2.01e-05	0.00036	CcSEcCtD
Cyproheptadine—Headache—Valproic Acid—epilepsy syndrome	2e-05	0.000358	CcSEcCtD
Cyproheptadine—Paraesthesia—Topiramate—epilepsy syndrome	2e-05	0.000358	CcSEcCtD
Cyproheptadine—Somnolence—Topiramate—epilepsy syndrome	1.98e-05	0.000355	CcSEcCtD
Cyproheptadine—Diarrhoea—Pregabalin—epilepsy syndrome	1.98e-05	0.000354	CcSEcCtD
Cyproheptadine—Dyspepsia—Topiramate—epilepsy syndrome	1.96e-05	0.000351	CcSEcCtD
Cyproheptadine—Amitriptyline—OPRM1—epilepsy syndrome	1.96e-05	0.0128	CrCbGaD
Cyproheptadine—Decreased appetite—Topiramate—epilepsy syndrome	1.94e-05	0.000347	CcSEcCtD
Cyproheptadine—Fatigue—Topiramate—epilepsy syndrome	1.92e-05	0.000344	CcSEcCtD
Cyproheptadine—Dizziness—Pregabalin—epilepsy syndrome	1.91e-05	0.000342	CcSEcCtD
Cyproheptadine—Constipation—Topiramate—epilepsy syndrome	1.91e-05	0.000341	CcSEcCtD
Cyproheptadine—Asthenia—Gabapentin—epilepsy syndrome	1.9e-05	0.00034	CcSEcCtD
Cyproheptadine—Nausea—Valproic Acid—epilepsy syndrome	1.9e-05	0.00034	CcSEcCtD
Cyproheptadine—Vomiting—Pregabalin—epilepsy syndrome	1.84e-05	0.000329	CcSEcCtD
Cyproheptadine—Feeling abnormal—Topiramate—epilepsy syndrome	1.84e-05	0.000329	CcSEcCtD
Cyproheptadine—Rash—Pregabalin—epilepsy syndrome	1.82e-05	0.000326	CcSEcCtD
Cyproheptadine—Dermatitis—Pregabalin—epilepsy syndrome	1.82e-05	0.000326	CcSEcCtD
Cyproheptadine—Loxapine—ADRA2A—epilepsy syndrome	1.82e-05	0.0118	CrCbGaD
Cyproheptadine—Diarrhoea—Gabapentin—epilepsy syndrome	1.81e-05	0.000325	CcSEcCtD
Cyproheptadine—Headache—Pregabalin—epilepsy syndrome	1.81e-05	0.000324	CcSEcCtD
Cyproheptadine—Carbamazepine—CYP2C19—epilepsy syndrome	1.79e-05	0.0117	CrCbGaD
Cyproheptadine—Clozapine—CHRM2—epilepsy syndrome	1.79e-05	0.0116	CrCbGaD
Cyproheptadine—Clozapine—HTR7—epilepsy syndrome	1.78e-05	0.0116	CrCbGaD
Cyproheptadine—Urticaria—Topiramate—epilepsy syndrome	1.77e-05	0.000317	CcSEcCtD
Cyproheptadine—Dizziness—Gabapentin—epilepsy syndrome	1.75e-05	0.000314	CcSEcCtD
Cyproheptadine—Mianserin—SLC6A4—epilepsy syndrome	1.74e-05	0.0114	CrCbGaD
Cyproheptadine—Nausea—Pregabalin—epilepsy syndrome	1.72e-05	0.000307	CcSEcCtD
Cyproheptadine—Vomiting—Gabapentin—epilepsy syndrome	1.69e-05	0.000302	CcSEcCtD
Cyproheptadine—Rash—Gabapentin—epilepsy syndrome	1.67e-05	0.000299	CcSEcCtD
Cyproheptadine—Dermatitis—Gabapentin—epilepsy syndrome	1.67e-05	0.000299	CcSEcCtD
Cyproheptadine—Amitriptyline—CHRM2—epilepsy syndrome	1.66e-05	0.0108	CrCbGaD
Cyproheptadine—Headache—Gabapentin—epilepsy syndrome	1.66e-05	0.000297	CcSEcCtD
Cyproheptadine—Amitriptyline—HTR7—epilepsy syndrome	1.65e-05	0.0108	CrCbGaD
Cyproheptadine—Asthenia—Topiramate—epilepsy syndrome	1.6e-05	0.000286	CcSEcCtD
Cyproheptadine—Nausea—Gabapentin—epilepsy syndrome	1.58e-05	0.000282	CcSEcCtD
Cyproheptadine—Nortriptyline—SLC6A4—epilepsy syndrome	1.56e-05	0.0101	CrCbGaD
Cyproheptadine—Diarrhoea—Topiramate—epilepsy syndrome	1.53e-05	0.000273	CcSEcCtD
Cyproheptadine—Clozapine—ADRA2A—epilepsy syndrome	1.52e-05	0.00993	CrCbGaD
Cyproheptadine—Nortriptyline—CYP2C19—epilepsy syndrome	1.48e-05	0.00962	CrCbGaD
Cyproheptadine—Dizziness—Topiramate—epilepsy syndrome	1.48e-05	0.000264	CcSEcCtD
Cyproheptadine—Vomiting—Topiramate—epilepsy syndrome	1.42e-05	0.000254	CcSEcCtD
Cyproheptadine—Amitriptyline—ADRA2A—epilepsy syndrome	1.42e-05	0.00923	CrCbGaD
Cyproheptadine—Rash—Topiramate—epilepsy syndrome	1.41e-05	0.000252	CcSEcCtD
Cyproheptadine—Dermatitis—Topiramate—epilepsy syndrome	1.41e-05	0.000251	CcSEcCtD
Cyproheptadine—Headache—Topiramate—epilepsy syndrome	1.4e-05	0.00025	CcSEcCtD
Cyproheptadine—Loxapine—SLC6A4—epilepsy syndrome	1.39e-05	0.00902	CrCbGaD
Cyproheptadine—Mianserin—HTR2A—epilepsy syndrome	1.34e-05	0.00873	CrCbGaD
Cyproheptadine—Nausea—Topiramate—epilepsy syndrome	1.33e-05	0.000237	CcSEcCtD
Cyproheptadine—Mianserin—CYP2D6—epilepsy syndrome	1.23e-05	0.00798	CrCbGaD
Cyproheptadine—Nortriptyline—HTR2A—epilepsy syndrome	1.2e-05	0.0078	CrCbGaD
Cyproheptadine—Clozapine—CYP2C19—epilepsy syndrome	1.1e-05	0.00718	CrCbGaD
Cyproheptadine—Nortriptyline—CYP2D6—epilepsy syndrome	1.1e-05	0.00713	CrCbGaD
Cyproheptadine—Amitriptyline—SLC6A4—epilepsy syndrome	1.08e-05	0.00704	CrCbGaD
Cyproheptadine—Loxapine—HTR2A—epilepsy syndrome	1.06e-05	0.00693	CrCbGaD
Cyproheptadine—Amitriptyline—CYP2C19—epilepsy syndrome	1.03e-05	0.00668	CrCbGaD
Cyproheptadine—Carbamazepine—ABCB1—epilepsy syndrome	9.5e-06	0.00618	CrCbGaD
Cyproheptadine—Clozapine—HTR2A—epilepsy syndrome	8.94e-06	0.00582	CrCbGaD
Cyproheptadine—Amitriptyline—HTR2A—epilepsy syndrome	8.31e-06	0.00541	CrCbGaD
Cyproheptadine—Nortriptyline—ALB—epilepsy syndrome	8.2e-06	0.00534	CrCbGaD
Cyproheptadine—Clozapine—CYP2D6—epilepsy syndrome	8.17e-06	0.00532	CrCbGaD
Cyproheptadine—Amitriptyline—CYP2D6—epilepsy syndrome	7.6e-06	0.00495	CrCbGaD
Cyproheptadine—Clozapine—ABCB1—epilepsy syndrome	5.84e-06	0.0038	CrCbGaD
Cyproheptadine—Amitriptyline—ALB—epilepsy syndrome	5.69e-06	0.0037	CrCbGaD
Cyproheptadine—Amitriptyline—ABCB1—epilepsy syndrome	5.43e-06	0.00353	CrCbGaD
Cyproheptadine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	1.11e-06	3.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	1.11e-06	3.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	1.11e-06	3.15e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-06	3.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-06	3.13e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCL2—epilepsy syndrome	1.1e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	1.1e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	1.1e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	1.09e-06	3.12e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.09e-06	3.11e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	1.09e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	1.08e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.08e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	1.07e-06	3.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	1.07e-06	3.05e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	1.06e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-06	3.01e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.04e-06	2.96e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	1.04e-06	2.95e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-06	2.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—POMC—epilepsy syndrome	1.02e-06	2.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	1.02e-06	2.91e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.02e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	1.02e-06	2.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	1.01e-06	2.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AGT—epilepsy syndrome	1.01e-06	2.88e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	1.01e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	1.01e-06	2.86e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	1e-06	2.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	1e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCL2—epilepsy syndrome	1e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	9.93e-07	2.83e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—FGF2—epilepsy syndrome	9.92e-07	2.82e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	9.9e-07	2.82e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—APOE—epilepsy syndrome	9.9e-07	2.82e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	9.89e-07	2.82e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	9.88e-07	2.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	9.87e-07	2.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	9.87e-07	2.81e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	9.87e-07	2.81e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	9.87e-07	2.81e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	9.85e-07	2.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	9.84e-07	2.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	9.84e-07	2.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	9.83e-07	2.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	9.82e-07	2.79e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	9.81e-07	2.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	9.81e-07	2.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	9.79e-07	2.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	9.75e-07	2.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	9.71e-07	2.76e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	9.7e-07	2.76e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	9.69e-07	2.76e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	9.67e-07	2.75e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	9.62e-07	2.74e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	9.59e-07	2.73e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	9.54e-07	2.72e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.52e-07	2.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.49e-07	2.7e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	9.47e-07	2.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	9.46e-07	2.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	9.44e-07	2.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	9.42e-07	2.68e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	9.42e-07	2.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	9.38e-07	2.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	9.37e-07	2.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	9.36e-07	2.66e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	9.33e-07	2.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	9.26e-07	2.64e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—RELA—epilepsy syndrome	9.21e-07	2.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	9.18e-07	2.61e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	9.16e-07	2.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	9.13e-07	2.6e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	9.13e-07	2.6e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	9.12e-07	2.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	9.1e-07	2.59e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	9.08e-07	2.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	9.07e-07	2.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—FGF2—epilepsy syndrome	9.05e-07	2.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	9.03e-07	2.57e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MTOR—epilepsy syndrome	9.03e-07	2.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	9.01e-07	2.56e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	8.96e-07	2.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	8.93e-07	2.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	8.91e-07	2.53e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	8.82e-07	2.51e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	8.67e-07	2.47e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	8.66e-07	2.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	8.53e-07	2.43e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	8.52e-07	2.43e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	8.51e-07	2.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—POMC—epilepsy syndrome	8.51e-07	2.42e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	8.5e-07	2.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	8.49e-07	2.42e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	8.49e-07	2.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	8.48e-07	2.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	8.46e-07	2.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	8.45e-07	2.4e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—RELA—epilepsy syndrome	8.41e-07	2.39e-05	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	8.38e-07	2.39e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	8.38e-07	2.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	8.37e-07	2.38e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	8.35e-07	2.38e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	8.33e-07	2.37e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	8.31e-07	2.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	8.31e-07	2.36e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	8.31e-07	2.36e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	8.3e-07	2.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	8.28e-07	2.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	8.26e-07	2.35e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MTOR—epilepsy syndrome	8.24e-07	2.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	8.2e-07	2.33e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	8.18e-07	2.33e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	8.16e-07	2.32e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	8.14e-07	2.32e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	8.12e-07	2.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	8.11e-07	2.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	8.08e-07	2.3e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—JUN—epilepsy syndrome	8.07e-07	2.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	8.03e-07	2.29e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	8e-07	2.28e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	7.97e-07	2.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	7.87e-07	2.24e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	7.86e-07	2.24e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	7.85e-07	2.23e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	7.84e-07	2.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	7.83e-07	2.23e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	7.83e-07	2.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	7.81e-07	2.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	7.8e-07	2.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	7.78e-07	2.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—epilepsy syndrome	7.75e-07	2.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	7.73e-07	2.2e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	7.7e-07	2.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.65e-07	2.18e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	7.61e-07	2.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CASP3—epilepsy syndrome	7.58e-07	2.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—JUN—epilepsy syndrome	7.36e-07	2.1e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	7.34e-07	2.09e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	7.3e-07	2.08e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	7.29e-07	2.08e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SRC—epilepsy syndrome	7.24e-07	2.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	7.17e-07	2.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—epilepsy syndrome	7.16e-07	2.04e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	7.16e-07	2.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	7.14e-07	2.03e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	7.13e-07	2.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	7.11e-07	2.02e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	7.05e-07	2.01e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	7.04e-07	2e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	7.02e-07	2e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	7e-07	1.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	6.98e-07	1.99e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	6.96e-07	1.98e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—epilepsy syndrome	6.95e-07	1.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	6.89e-07	1.96e-05	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—epilepsy syndrome	6.83e-07	1.94e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	6.82e-07	1.94e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	6.78e-07	1.93e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	6.78e-07	1.93e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	6.68e-07	1.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	6.65e-07	1.89e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SRC—epilepsy syndrome	6.61e-07	1.88e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	6.45e-07	1.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—epilepsy syndrome	6.43e-07	1.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	6.34e-07	1.81e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	6.33e-07	1.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	6.31e-07	1.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	6.29e-07	1.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	6.23e-07	1.77e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.21e-07	1.77e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	6.17e-07	1.76e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	6.15e-07	1.75e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	6.12e-07	1.74e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	5.98e-07	1.7e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	5.97e-07	1.7e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	5.94e-07	1.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	5.89e-07	1.68e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	5.88e-07	1.67e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	5.87e-07	1.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	5.86e-07	1.67e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	5.84e-07	1.66e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	5.81e-07	1.65e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	5.78e-07	1.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	5.78e-07	1.65e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	5.77e-07	1.64e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	5.76e-07	1.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	5.74e-07	1.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	5.73e-07	1.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	5.67e-07	1.61e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.63e-07	1.6e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	5.61e-07	1.6e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.45e-07	1.55e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	5.4e-07	1.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.36e-07	1.53e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	5.36e-07	1.52e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.35e-07	1.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.33e-07	1.52e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	5.33e-07	1.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	5.32e-07	1.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	5.31e-07	1.51e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	5.3e-07	1.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	5.28e-07	1.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	5.27e-07	1.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	5.26e-07	1.5e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	5.24e-07	1.49e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.22e-07	1.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	5.21e-07	1.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	5.19e-07	1.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	5.16e-07	1.47e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	5.15e-07	1.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	5.13e-07	1.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	5.12e-07	1.46e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	5.1e-07	1.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	5.07e-07	1.44e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	5.02e-07	1.43e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	5.01e-07	1.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	4.99e-07	1.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	4.98e-07	1.42e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	4.95e-07	1.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	4.93e-07	1.4e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.87e-07	1.39e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	4.86e-07	1.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.84e-07	1.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	4.83e-07	1.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	4.78e-07	1.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	4.7e-07	1.34e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	4.63e-07	1.32e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	4.62e-07	1.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	4.6e-07	1.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	4.59e-07	1.31e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	4.58e-07	1.3e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	4.54e-07	1.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.51e-07	1.28e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	4.5e-07	1.28e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	4.5e-07	1.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	4.48e-07	1.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	4.47e-07	1.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	4.43e-07	1.26e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—epilepsy syndrome	4.1e-07	1.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—epilepsy syndrome	3.41e-07	9.71e-06	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.33e-07	9.47e-06	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	3.31e-07	9.43e-06	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	2.92e-07	8.32e-06	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	2.88e-07	8.18e-06	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	2.87e-07	8.17e-06	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.86e-07	8.14e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	2.85e-07	8.12e-06	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	2.82e-07	8.04e-06	CbGpPWpGaD
